Clinical Trial Update: Ranibizumab in Patients With Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ranibizumab in patients with branch retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Retinal Vein Occlusion | Phase 4 | Status: COMPLETED